VRTX stock news
This page provides real-time market news, earnings updates, and company announcements related to Vertex Pharmaceuticals Incorporated (VRTX).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-16 07:45 EST
Intellia Therapeutics, Inc. (NTLA): A Bull Case Theory
Finviz2026-02-28 15:09:06
Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer
Finviz2026-03-03 13:03:53
Top Research Reports for Broadcom, AT&T & Vertex Pharmaceuticals
Finviz2026-03-03 23:06:27
Bank of America Securities Maintains $370 Price Target on Alphabet (GOOGL)
Finviz2026-03-05 00:45:40
Amazon, Google And Microsoft Keep Anthropic AI For Clients Despite Pentagon Risk Label
Finviz2026-03-07 04:51:44
AvePoint Announces General Availability of AgentPulse Command Center, with Multicloud Agentic AI Governance
Finviz2026-03-09 13:03:58
SailPoint redefines identity security with new adaptive identity innovations
Finviz2026-03-09 13:03:58
Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-09 20:09:53
Vertex Pharmaceuticals announced positive interim results at week 36 from the phase III clinical trial (code-named Rainier) of its investigational drug Povetacicept for adult IgA nephropathy.
老虎证券2026-03-09 20:23:59
US Stock Movement | Vertex Pharmaceuticals (VRTX.US) surges after hours as late-stage trial of kidney drug povetacicept meets expected targets
老虎证券2026-03-10 00:29:37
CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering
Finviz2026-03-10 11:07:14
Here is Why CRISPR Therapeutics (CRSP) Appears so Good
Finviz2026-03-10 12:06:51
Vertex's New Kidney Drug Delivers Big Trial Win, Stock Jumps
Finviz2026-03-10 13:43:05
CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering
Finviz2026-03-11 11:03:53
Vertex Achieves Remarkable Growth, Sets New Industry Standard with ServiceTitan
Finviz2026-03-12 20:18:07
Vertex Now Available on Oracle Marketplace
Finviz2026-03-17 12:33:49
Cisco Reimagines Security for the Agentic Workforce
Finviz2026-03-23 12:03:49
Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-24 20:12:10
3D Systems Achieves Full-Scope EU MDR Certification, Accelerating European Launch of NextDent Jetted Denture Solution Targeted for Summer 2026
Finviz2026-03-25 12:21:46
Recently, FOTAI Pharma announced that its drugs Alyftrek® and Trikafta® have received label expansion approval from the U.S. Food and Drug Administration (FDA).
老虎证券2026-04-01 11:49:25
MIMEDX to Sponsor Leading Advanced Wound Care Conferences
Finviz2026-04-02 13:18:43
Vertex Advances AI-Powered Capabilities to Improve How Enterprises Execute Compliance
Finviz2026-04-07 12:03:44
Sam Altman's sky collapsed twice in one day
爱范儿2026-04-07 17:39:57
Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
Finviz2026-04-10 13:57:05
Amazon, Google And Microsoft Keep Anthropic AI For Clients Despite Pentagon Risk Label
Finviz2026-03-07 04:51:44
AvePoint Announces General Availability of AgentPulse Command Center, with Multicloud Agentic AI Governance
Finviz2026-03-09 13:03:58
SailPoint redefines identity security with new adaptive identity innovations
Finviz2026-03-09 13:03:58
Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-09 20:09:53
Vertex Pharmaceuticals announced positive interim results at week 36 from the phase III clinical trial (code-named Rainier) of its investigational drug Povetacicept for adult IgA nephropathy.
老虎证券2026-03-09 20:23:59
US Stock Movement | Vertex Pharmaceuticals (VRTX.US) surges after hours as late-stage trial of kidney drug povetacicept meets expected targets
老虎证券2026-03-10 00:29:37
CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering
Finviz2026-03-10 11:07:14
Here is Why CRISPR Therapeutics (CRSP) Appears so Good
Finviz2026-03-10 12:06:51
Vertex's New Kidney Drug Delivers Big Trial Win, Stock Jumps
Finviz2026-03-10 13:43:05
CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering
Finviz2026-03-11 11:03:53
Vertex Achieves Remarkable Growth, Sets New Industry Standard with ServiceTitan
Finviz2026-03-12 20:18:07
Vertex Now Available on Oracle Marketplace
Finviz2026-03-17 12:33:49
Cisco Reimagines Security for the Agentic Workforce
Finviz2026-03-23 12:03:49
Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-24 20:12:10
3D Systems Achieves Full-Scope EU MDR Certification, Accelerating European Launch of NextDent Jetted Denture Solution Targeted for Summer 2026
Finviz2026-03-25 12:21:46
Recently, FOTAI Pharma announced that its drugs Alyftrek® and Trikafta® have received label expansion approval from the U.S. Food and Drug Administration (FDA).
老虎证券2026-04-01 11:49:25
MIMEDX to Sponsor Leading Advanced Wound Care Conferences
Finviz2026-04-02 13:18:43
Vertex Advances AI-Powered Capabilities to Improve How Enterprises Execute Compliance
Finviz2026-04-07 12:03:44
Sam Altman's sky collapsed twice in one day
爱范儿2026-04-07 17:39:57
Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
Finviz2026-04-10 13:57:05
VRTX stock chart
VRTX stock detailsVRTX stock price change
On the last trading day, VRTX stock closed at 441.70 USD, with a price change of -0.58% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more